BOTANICAL COMBINATION OF CURCUMIN AND COPTIS CHINESE FOR THE TREATMENT OF POST-DIVERTICULITS SYMPTOMATIC UNCOMPLICATED DIVERTICULAR DISEASE: RESULTS OF A PHASE 1B STUDY

被引：0
|
作者：
Lahat, Adi
Salomon, Nir
Neuman, Sandra
Dvir, Revital
Farkash, Hadar
Kopylov, Uri
Ben-Horin, Shomron
机构：
来源：
GASTROENTEROLOGY | 2024年 / 166卷 / 05期
关键词：
D O I：
暂无
中图分类号：
R57 [消化系及腹部疾病];
学科分类号：
摘要：
Mo1350
引用
收藏
页码：S1035 / S1035
页数：1
相关论文
共 50 条
  • [1] A phase 1b study of atezolizumab in combination with guadecitabine for the treatment of acute myeloid leukemia
    Prebet, Thomas
    Goldberg, Aaron D.
    Jurcic, Joseph G.
    Khaled, Samer
    Dail, Monique
    Feng, Yuning
    Green, Cherie
    Li, Chunze
    Ma, Connie
    Medeiros, Bruno C.
    Yan, Mark
    Grunwald, Michael R.
    LEUKEMIA & LYMPHOMA, 2022, 63 (09) : 2180 - 2188
  • [2] Selinexor in Combination with R-CHOP for Frontline Treatment of Non-Hodgkin Lymphoma: Results of a Phase 1b Study
    Seymour, Erlene K.
    Li, Yiwei
    Aboukameel, Amro
    Ramchandren, Radhakrishnan
    Sterbis, Golbon
    Yang, Jay
    Bhutani, Divaya
    Mohammad, Ramzi
    Azmi, Asfar Sohail
    Zonder, Jeff
    BLOOD, 2020, 136
  • [3] Results from a Phase 1b/2 Study of Ibrutinib Combination Therapy in Advanced Urothelial Carcinoma
    Mar, Nataliya
    Zakharia, Yousef
    Falcon, Alejandro
    Morales-Barrera, Rafael
    Mellado, Begona
    Duran, Ignacio
    Oh, Do-Youn
    Williamson, Stephen K.
    Gajate, Pablo
    Arkenau, Hendrik-Tobias
    Jones, Robert J.
    Teo, Min Yuen
    Turan, Tolga
    McLaughlin, Robert T.
    Peltier, Hillary M.
    Chong, Elizabeth
    Atluri, Harisha
    Dean, James P.
    Castellano, Daniel
    CANCERS, 2023, 15 (11)
  • [4] Subcutaneous Teclistamab in Combination with Daratumumab for the Treatment of Patients with Relapsed/Refractory Multiple Myeloma: Results from a Phase 1b Multicohort Study
    Rodriguez-Otero, Paula
    Dholaria, Bhagirathbhai
    Askari, Elham
    Reece, Donna E.
    van de Donk, Niels W. C. J.
    Chari, Ajai
    Goldschmidt, Hartmut
    Krishnan, Amrita Y.
    Martin, Thomas
    Mateos, Maria-Victoria
    Giles, Daniel Morillo
    Rodriguez, Cesar
    Rosinol, Laura
    San-Miguel, Jesus F.
    Sureda, Anna
    Waesch, Ralph
    Weisel, Katja
    Verona, Raluca I.
    Lin, Shun Xin Wang
    Prior, Thomas J.
    Weiss, Brendan M.
    Wade, Mark
    Goldberg, Jenna D.
    Oriol, Albert
    Hari, Parameswaran
    BLOOD, 2021, 138
  • [5] Safety and pharmacokinetics of motesanib in combination with gemcitabine and erlotinib for the treatment of solid tumors: a phase 1b study
    Kotasek, Dusan
    Tebbutt, Niall
    Desai, Jayesh
    Welch, Stephen
    Siu, Lillian L.
    McCoy, Sheryl
    Sun, Yu-Nien
    Johnson, Jessica
    Adewoye, Adeboye H.
    Price, Timothy
    BMC CANCER, 2011, 11
  • [6] Phase 1b study of lenvatinib (E7080) in combination with temozolomide for treatment of advanced melanoma
    Hong, David S.
    Kurzrock, Razelle
    Falchook, Gerald S.
    Andresen, Corina
    Kwak, Jennifer
    Ren, Min
    Xu, Lucy
    George, Goldy C.
    Kim, Kevin B.
    Nguyen, Ly M.
    O'Brien, James P.
    Nemunaitis, John
    ONCOTARGET, 2015, 6 (40) : 43127 - 43134
  • [7] Safety and pharmacokinetics of motesanib in combination with gemcitabine and erlotinib for the treatment of solid tumors: a phase 1b study
    Dusan Kotasek
    Niall Tebbutt
    Jayesh Desai
    Stephen Welch
    Lillian L Siu
    Sheryl McCoy
    Yu-Nien Sun
    Jessica Johnson
    Adeboye H Adewoye
    Timothy Price
    BMC Cancer, 11
  • [8] Ibrutinib combination therapy for advanced gastrointestinal and genitourinary tumours: results from a phase 1b/2 study
    Do-Youn Oh
    Maria Alsina Maqueda
    David I. Quinn
    Peter J. O’Dwyer
    Ian Chau
    Sun Young Kim
    Ignacio Duran
    Daniel Castellano
    Jordan Berlin
    Begona Mellado
    Stephen K. Williamson
    Keun-Wook Lee
    Francisca Marti
    Paul Mathew
    Muhammad Wasif Saif
    Ding Wang
    Elizabeth Chong
    Jacqueline Hilger-Rolfe
    James P. Dean
    Hendrik-Tobias Arkenau
    BMC Cancer, 23
  • [9] Ibrutinib combination therapy for advanced gastrointestinal and genitourinary tumours: results from a phase 1b/2 study
    Oh, Do-Youn
    Maqueda, Maria Alsina
    Quinn, David I.
    O'Dwyer, Peter J.
    Chau, Ian
    Kim, Sun Young
    Duran, Ignacio
    Castellano, Daniel
    Berlin, Jordan
    Mellado, Begona
    Williamson, Stephen K.
    Lee, Keun-Wook
    Marti, Francisca
    Mathew, Paul
    Saif, Muhammad Wasif
    Wang, Ding
    Chong, Elizabeth
    Hilger-Rolfe, Jacqueline
    Dean, James P.
    Arkenau, Hendrik-Tobias
    BMC CANCER, 2023, 23 (01)
  • [10] Phase 1b/2 study of olaratumab plus gemcitabine and docetaxel for the treatment of advanced soft tissue sarcoma (STS) (ANNOUNCE 2): Phase 1b results.
    Villalobos, Victor Manuel
    Redondo, Andres
    Van Tine, Brian Andrew
    Schwartz, Gary K.
    Dickson, Mark Andrew
    Chmielowski, Bartosz
    Peterson, Patrick
    Cronier, Damien
    Wright, Jennifer A.
    Attia, Steven
    JOURNAL OF CLINICAL ONCOLOGY, 2018, 36 (15)
12345